Rigel Pharmaceuticals, Inc. (RIGL) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $1.14 +0.88%
EPS Growth %: +62.5%
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
SFST, VLTO, CLIR, More
EPS Growth %: +62.5%
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q2 EPS of ($0.29), $0.04 worse than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Texas Instruments (TXN) jumps on first above-consensus guide in seven years
- Eastgroup Properties (EGP) Tops Q1 EPS by 17c, provides guidance
- Matador Resources (MTDR) Tops Q1 EPS by 16c; provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
